Your dog was diagnosed with Multicentric T-Cell Lymphoma. Accounts for 15-30% of canine multicentric lymphoma cases. Carries a significantly worse prognosis than B-cell lymphoma. More frequently associated with hypercalcaemia and mediastinal involvement. Compare 6 treatment options for dogs including CHOP Protocol, COP Protocol, Single-Agent Doxorubicin — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Multicentric T-Cell Lymphoma
Canine Oncology Treatment Guide
Multicentric T-Cell Lymphoma
WHO Stage III-V
Round Cell
About This Cancer
T-cell lymphoma arises from T-lymphocytes, the white blood cells that normally coordinate immune responses and destroy infected cells. Like B-cell lymphoma, it typically presents with widespread lymph node enlargement, but T-cell lymphoma carries a significantly worse prognosis. T-cell disease accounts for roughly 15–30% of multicentric lymphoma cases in dogs and is more frequently associated with elevated blood calcium levels (hypercalcaemia), which can cause increased thirst, urination, and kidney problems as a secondary complication. The cancer tends to respond less completely to standard chemotherapy protocols, and remission times are typically shorter than for B-cell lymphoma. Boxers, Golden Retrievers, and Siberian Huskies appear to be at higher risk.
WHO Clinical Staging for Canine Lymphoma
Same staging system as B-cell. T-cell lymphoma more commonly presents with hypercalcaemia and mediastinal involvement.
Prognostic Factors(5)
Minimum Workup(8 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.